Voluntary nationwide recall: Prograf and Astagraf (Astellas – December)

Jan. 2025Pharmacy Updates

Astellas Pharma US, Inc. is recalling one lot of Prograf, lot 0E3353D, and one lot of Astagraf XL, lot 0R3092A. Prograf and Astagraf XL are used in conjunction with other medicines to help prevent organ transplant rejection.

These drugs are being recalled because bottles may contain empty capsules. Using empty capsules may result in organ transplant rejection that may be fatal.

To see if your medication was recalled, contact your doctor or pharmacy where you received it or visit the FDA website below. If you have an affected lot of Prograf or Astagraf XL, you should stop using the product and contact your pharmacy where you received it for a replacement.

As of Dec. 26, there had been no reports of adverse events related to this recall.

To learn more about this recall, you can take one or more of the steps below.

  • Talk to your doctor or pharmacist.
  • Call Astellas Medical Information at 1-800-727-7003. TTY users should call 711. Help is available Monday through Friday from 9 a.m. to 5:30 p.m. EST.
  • Visit the FDA website.

Recent Announcements

Access member care plans in UPMC Health Plan Tapestry Link

Starting Dec. 1, 2026, providers will be able to access SNP care plans within UPMC Health Plan Tapestry Link. Care plans are visible on a member’s chart in multiple locations:
Nov. 2026Important Notices

UPMC Health Plan Tapestry Link resources available

UPMC Health Plan Tapestry Link will launch on Tuesday, Dec. 1, 2026. To help ease your transition to the new platform, we have developed the following resources:
Nov. 2026Important Notices

Changes to inpatient denial and OBS claim billing

We will soon transition to the Epic® platform. This change will align our claims processing with industry standards by adjudicating claims based on the level of care authorized. As this transition approaches, please keep the following areas in mind:
Nov. 2026